Related Experiment Video

Updated: Aug 24, 2026

Transient Transduction of the Strobilated Forms of Echinococcus granulosus
13:25

Transient Transduction of the Strobilated Forms of Echinococcus granulosus

Published on: September 16, 2022

[Cardiopericardial echinococcosis]

Abdallah Mahdhaoui1, Hatem Bouraoui, Mohamed Amine Majdoub

  • 1Service de cardiologie Hôpital Farhat Hached 4000 Sousse, Tunisie. Abdallah.Mahdhaoui@famso.rnu.tn

Revue Medicale De La Suisse Romande
|April 21, 2004
PubMed

Insights

Cardiac echinococcosis is rare, but transthoracic echocardiography (TTE) and transesophageal echocardiography (TEE) are effective for diagnosis. These imaging techniques aid in identifying cardiac hydatid cysts, even with atypical symptoms in endemic areas.

Area of Science:

  • Cardiology
  • Parasitology
  • Medical Imaging

Context:

  • Cardiac hydatid cysts are uncommon, accounting for 0.5-2% of human echinococcosis cases.
  • This study reviews 12 patients diagnosed with cardiac echinococcosis between 1992 and 2001.

Purpose:

  • To describe the clinical and echographic features of cardiac echinococcosis.
  • To evaluate the diagnostic utility of various imaging modalities for cardiac hydatid cysts.

Summary:

  • The study analyzed 12 patients (average age 40) with cardiac hydatid cysts located in the ventricles, atria, or pericardial cavity.
  • Transthoracic echocardiography (TTE) and transesophageal echocardiography (TEE) were diagnostic in all cases, with CT and MRI providing additional information on disease extent.
  • Surgical intervention was performed on all patients, resulting in one postoperative death and no late recurrences or complications.

Impact:

  • Highlights the importance of considering cardiac echinococcosis in patients from endemic regions with unusual symptoms.
  • Establishes TTE and TEE as primary imaging modalities for diagnosing cardiac hydatid cysts.
  • Demonstrates the effectiveness of surgical treatment and the low recurrence rate for cardiac echinococcosis.
Abstract

More Related Videos

Transthoracic Echocardiographic Examination in the Rabbit Model14:46

Transthoracic Echocardiographic Examination in the Rabbit Model

Published on: June 1, 2019

Related Concept Videos

Imaging Studies for Cardiovascular System I:Echocardiography01:17

Imaging Studies for Cardiovascular System I:Echocardiography

Cardiac imaging studies encompass a wide range of noninvasive and minimally invasive techniques designed to visualize the heart's structure and function in detail. One such technique is echocardiography, which uses high-frequency ultrasound waves to produce detailed images of the heart, known as echocardiograms.
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion, evaluates...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...